111 Posts
The emergence of a new class of immunotherapy drugs has stirred optimism in the fight against cancer.
Clinical trials have propelled medical advances for centuries, and they are just as influential today. But low participation could stall progress.
Researchers at the National Cancer Institute have announced a breakthrough that may take light-based cancer therapy to the next level.
Guidelines
The information contained in this blog is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in the blog is intended to be used for medical diagnosis or treatment of any illness, condition or disease.